Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-17 5:07 pm Purchase | 2024-05-15 | 13G | Pieris Pharmaceuticals, Inc. PIRS | BIOTECHNOLOGY VALUE FUND L P | 257,622 19.500% | 257,622 (New Position) | Filing History |
| 2024-03-05 4:59 pm Unchanged | 2024-02-29 | 13D | MoonLake Immunotherapeutics MLTX | BIOTECHNOLOGY VALUE FUND L P | 21,751,284 34.600% | 0 (Unchanged) | Filing History |
| 2024-02-22 4:45 pm Unchanged | 2024-02-20 | 13G | enGene Holdings Inc. Common Stock ENGN | BIOTECHNOLOGY VALUE FUND L P | 3,196,439 7.200% | 0 (Unchanged) | Filing History |
| 2024-02-14 10:30 am Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -3,360,941 (Position Closed) | Filing History |
| 2024-02-14 10:28 am Sale | 2023-12-31 | 13G | Rein Therapeutics Inc. RNTX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -236,835 (Position Closed) | Filing History |
| 2024-02-14 10:26 am Purchase | 2023-12-31 | 13G | Annexon, Inc. ANNX | BIOTECHNOLOGY VALUE FUND L P | 7,000,000 8.900% | 3,219,306 (+85.15%) | Filing History |
| 2024-02-14 10:24 am Purchase | 2023-12-31 | 13G | Aravive, Inc. ARAV | BIOTECHNOLOGY VALUE FUND L P | 8,164,510 9.990% | 2,055,452 (+33.65%) | Filing History |
| 2024-02-14 10:22 am Purchase | 2023-12-31 | 13G | ASLAN Pharmaceuticals Limited ASLN | BIOTECHNOLOGY VALUE FUND L P | 5,418,122 9.990% | 5,418,122 (New Position) | Filing History |
| 2024-02-14 10:20 am Sale | 2023-12-31 | 13G | Bionomics Limited BNOX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -14,174,157 (Position Closed) | Filing History |
| 2024-02-14 10:18 am Purchase | 2023-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | BIOTECHNOLOGY VALUE FUND L P | 463,776 9.990% | 120,720 (+35.19%) | Filing History |
| 2024-02-14 10:16 am Sale | 2023-12-31 | 13G | Cullinan Oncology, Inc. CGEM | BIOTECHNOLOGY VALUE FUND L P | 4,393,321 9.990% | -3,115,738 (-41.49%) | Filing History |
| 2024-02-14 10:13 am Purchase | 2023-12-31 | 13G | Centessa Pharmaceuticals plc CNTA | BIOTECHNOLOGY VALUE FUND L P | 8,774,570 9.000% | 1,880,225 (+27.27%) | Filing History |
| 2024-02-14 10:11 am Sale | 2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -2,736,613 (Position Closed) | Filing History |
| 2024-02-14 10:09 am Purchase | 2023-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | BIOTECHNOLOGY VALUE FUND L P | 6,702,889 9.990% | 107,088 (+1.62%) | Filing History |
| 2024-02-14 10:08 am Purchase | 2023-12-31 | 13G | Delcath Systems, Inc. DCTH | BIOTECHNOLOGY VALUE FUND L P | 2,338,426 9.990% | 776,912 (+49.75%) | Filing History |
| 2024-02-14 10:06 am Purchase | 2023-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BIOTECHNOLOGY VALUE FUND L P | 4,326,710 17.900% | 2,000,000 (+85.96%) | Filing History |
| 2024-02-14 10:01 am Purchase | 2023-12-31 | 13G | Elevation Oncology, Inc. ELEV | BIOTECHNOLOGY VALUE FUND L P | 4,450,885 9.990% | 2,138,685 (+92.50%) | Filing History |
| 2024-02-14 09:58 am Purchase | 2023-12-31 | 13G | 89bio, Inc. ETNB | BIOTECHNOLOGY VALUE FUND L P | 7,568,480 7.800% | 4,047,354 (+114.94%) | Filing History |
| 2024-02-14 09:56 am Unchanged | 2023-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | BIOTECHNOLOGY VALUE FUND L P | 4,007,413 9.400% | 0 (Unchanged) | Filing History |
| 2024-02-14 09:54 am Purchase | 2023-12-31 | 13G | GH Research PLC GHRS | BIOTECHNOLOGY VALUE FUND L P | 10,400,158 19.990% | 1,125,000 (+12.13%) | Filing History |